Financials

News Discussions Technicals Seasonals

087010 fundamentals

Overview Statements Statistics Dividends Earnings Revenue

Key facts

—

—

—

—

—

—

—

—

About

Peptron, Inc. engages in the development of peptide-based medicines and novel drugs. Its products include medicines for prostate cancer, hyperpituitarism, diabetes, degenerative neuronal disease, and obesity, peptide materials, and cosmetics. The company was founded on November 21, 1997 and is headquartered in Daejeon, South Korea.

Valuation

Fundamental metrics to determine fair value of the stock

Summary

No data available

There's currently no market capitalization, revenue or net income data to show.

Valuation ratios

Growth and Profitability

Company’s recent performance and margins

Dividends

Dividend yield, history and sustainability

No dividends

087010 has never paid dividends and has no current plans to do so.

Financial health

Financial position and solvency of the company